Results from an early safety study of Moderna's coronavirus vaccine candidate in older adults showed that it produced virus-neutralizing antibodies at levels similar to those seen in younger adults, with side effects roughly on par with high-dose flu shots. This report produced by Jillian Kitchener.
With "My Queue" you can quickly save videos to watch later.
To add an item to your queue just click the sign next to the video.
Once you've added a video visit "My Queue" to start watching!